 ceftazidime/clindamycin versu tobramycin/clindamycin treatment intra-abdomin infect order efficaci toxic ceftazidim substitut aminoglycosid treatment intra-abdomin sepsi prospect trial ninety-four patient trauma ceftazidime/clindamycin caz/c tobramycin/clindamycin t/c caz gm gm hour dosag peak mg/l mg/l concentr age sex baselin serum creatinin etiolog infect compar group clinic cure similar culture-posit culture-neg patient caz/c vs clinic cure rate t/c cultur posit cultur neg patient pathogen organ caz/c t/c patient nephrotox nephrotox ototox none caz/c patient t/c patient caz/c bacteria patient signific differ clinic respons culture-posit patient find lack toxic caz/c effect altern treatment iai